This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yingxia Xu and His Patent in Angiopoietin-Like Protein 3 Antibodies.
Introduction
Yingxia Xu is an inventor based in Shanghai, China. His patent work includes an antibody and pharmaceutical composition targeting angiopoietin-like protein 3 (ANGPTL3).
Latest Patents
Xu is associated with 1 patent: “Anti-Angiopoietin-Like Protein 3 (ANGPTL3) Antibody and Pharmaceutical Composition Thereof.” The patent concerns an antibody and a pharmaceutical composition directed at ANGPTL3.
Career Highlights
Xu’s listed patent is associated with Jiangsu Hengrui Pharmaceuticals Co., Ltd., a pharmaceutical company. The available information identifies his work through this patent and does not provide further details about his career.
Collaborations
Yayuan Fu and Bing Lin are listed as Xu’s coworkers.
Conclusion
Yingxia Xu’s patent activity includes work on an ANGPTL3 antibody and its pharmaceutical composition, associated with Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile